Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Free Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04883827
What this trial is testing

Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer

Who this might be right for
Renal Cell Carcinoma
Vanderbilt-Ingram Cancer Center 180
Not applicableLooking for participantsNCT06071286
What this trial is testing

SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTS

Who this might be right for
Ovarian Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 30
Large-scale testing (Phase 3)Ended earlyNCT00003824
What this trial is testing

S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
SWOG Cancer Research Network 114
Large-scale testing (Phase 3)Looking for participantsNCT05764044
What this trial is testing

Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer

Who this might be right for
Cervical CancerCervix CancerCervix Neoplasm
Hospital do Coracao 365
Not applicableStudy completedNCT00700531
What this trial is testing

European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy

Who this might be right for
Multiple MyelomaCast NephropathyKidney Failure
University Hospital Birmingham 90
Testing effectiveness (Phase 2)Looking for participantsNCT07586826
What this trial is testing

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

Who this might be right for
Persistent Isolated Chemotherapy-Induced ThrombocytopeniaChemotherapy-Induced ThrombocytopeniaGynecologic Cancers+7 more
Peking University People's Hospital 220
Not applicableStudy completedNCT07723443
What this trial is testing

Effects of Folic Acid and Vitamin E on Hormones in Polycystic Ovary Syndrome

Who this might be right for
PCOS (Polycystic Ovary Syndrome)
Al-Mustansiriyah University 207
Large-scale testing (Phase 3)Not Yet RecruitingNCT07269691
What this trial is testing

RaSOLVE: 125I Radioactive Seed Marking Effects on Pathological Complete Response Rate and Prognosis Post-Neoadjuvant Therapy in Early/Advanced Breast Cancer

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)Breast Cancer
Pengfei Qiu 194
Not applicableStudy completedNCT06595758
What this trial is testing

This Study Investigates the Impact of Single Nucleotide Polymorphisms in Genes Involved in the Pharmacokinetics and Toxicity of Doxorubicin (DOX) in Egyptian Female Patients with Breast Cancer. It Also Aims to Explore the Association of Pretreatment Neutrophil to Lymphocyte Ratio to PCR

Who this might be right for
Breast Cancer
Menoufia University 100
Not applicableLooking for participantsNCT06726642
What this trial is testing

CfDNA in Hereditary And High-risk Malignancies 2

Who this might be right for
Hereditary Cancer Syndrome
University Health Network, Toronto 1,000
Not applicableLooking for participantsNCT06836869
What this trial is testing

Modified Tumor-free Techniques Operation to Cervical Cancer

Who this might be right for
Cervical Cancer Stage IB2
Peking Union Medical College Hospital 524
Not applicableLooking for participantsNCT05366881
What this trial is testing

CfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Who this might be right for
Brain CancerBreast CancerBladder Cancer+17 more
Adela, Inc 7,000
Large-scale testing (Phase 3)UnknownNCT00902954
What this trial is testing

Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer

Who this might be right for
Breast Cancer
Fudan University 540
Large-scale testing (Phase 3)Active Not RecruitingNCT01844986
What this trial is testing

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

Who this might be right for
Newly DiagnosedAdvanced Ovarian CancerFIGO Stage III-IV+4 more
AstraZeneca 450
Not applicableUnknownNCT05310305
What this trial is testing

PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer

Who this might be right for
Immune Checkpoint InhibitorsAnti-programmed Death-1 AntibodyRadiotherapy+7 more
Lei Li 20
Large-scale testing (Phase 3)UnknownNCT00382070
What this trial is testing

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 3,966
Not applicableUnknownNCT00309920
What this trial is testing

Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer

Who this might be right for
Breast Cancer
Heinrich-Heine University, Duesseldorf 1,234
Not applicableStudy completedNCT03066310
What this trial is testing

Urine-DNA Biomarkers in Detecting Bladder Cancer

Who this might be right for
Bladder CancerBiomarkerDiagnosis+1 more
Xiangya Hospital of Central South University 125
Large-scale testing (Phase 3)UnknownNCT04764487
What this trial is testing

A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanced Renal Cell Carcinoma Treated With Axitinib/Pembrolizumab in First Line

Who this might be right for
Renal Cell Carcinoma Metastatic
Weprom 178
Not applicableLooking for participantsNCT04049604
What this trial is testing

IDENTIFY Study: Natural History of Maternal Neoplasia

Who this might be right for
Maternal Neoplasia
National Human Genome Research Institute (NHGRI) 365
Next Page